Alzheimer disease: Evidence for a central pathogenic role of iron-mediated reactive oxygen species

Journal of Alzheimer's Disease

Volumn 6, Issue 2, 2004, Pages 165-169

  Casadesus, Gemma ^a   Smith, Mark A ^a   Zhu, Xiongwei ^a   Aliev, Gjumrakch ^a   Cash, Adam D ^a   Honda, Kazuhiro ^a   Petersen, Robert B ^a   Perry, George ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Copper; Iron; Mitochondria; Oxidative stress; Redox metals

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; HYDROXYL RADICAL; IRON; IRON CHELATING AGENT; METALLOPROTEIN; NUCLEIC ACID; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BRAIN MITOCHONDRION; CATALYSIS; CYTOSKELETON; CYTOSOL; DEGENERATIVE DISEASE; HOMEOSTASIS; HUMAN; IRON CHELATION; KNOCKOUT MOUSE; METAL BINDING; NEUROPATHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REACTION ANALYSIS; REVIEW;

EID: 2342429376     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2004-6208     Document Type: Review

References (47)

1. C.S. Atwood, R.D. Moir, X. Huang, R.C. Scarpa, N.M. Bacarra, D.M. Romano, M.A. Hartshorn, R.E. Tanzi and A.I. Bush, Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis, J Biol Chem 273 (1998), 12817-12826.
2. C.S. Atwood, S.R. Robinson and M.A. Smith, Amyloid-β: redox-metal chelator and antioxidant, J Alzheimers Dis 4 (2002), 203-214.
3. C.S. Atwood, M.A. Smith, R.N. Martins, R.E. Tanzi, A.E. Roher, A.I. Bush and G. Perry, Neuroinflammatory environments promote amyloid-β deposition and posttranslational modification, in: Neuroinflammation: Mechanisms and Management, 2nd edition, P.L. Wood, ed., Humana Press Inc., Totowa, New Jersey, 2003, pp. 249-266.
4. C. Bergeron, S. Muntasser, M.J. Somerville, L. Weyer and M.E. Percy, Copper/zinc superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis motorneurons, Brain Res 659 (1994), 272-276.
5. G.M. Bishop, S.R. Robinson, Q. Liu, G. Perry, C.S. Atwood and M.A. Smith, Iron: A pathological mediator of Alzheimer disease? Dev Neurosci 24 (2002), 184-187.
6. L.I. Bruijn, M.K. Houseweart, S. Kato, K.L. Anderson, S.D. Anderson, E. Ohama, A.G. Reaume, R.W. Scott and D.W. Cleveland, Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1, Science 281 (1998), 1851-1854.
7. A.I. Bush, Metal complexing agents as therapies for Alzheimer's disease, Neurobiol Aging 23 (2002), 1031-1038.
8. A.D. Cash, G. Aliev, S.L. Siedlak, A. Nunomura, H. Fujioka, X. Zhu, A.K. Raina, H.V. Vinters, M. Tabaton, A.B. Johnson, M. Paula-Barbosa, J. Avila, P.K. Jones, R.J. Castellani, M.A. Smith and G. Perry, Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation, Am J Pathol 162 (2003), 1623-1627.
9. R. Castellani, M.A. Smith, P.L. Richey, R. Kalaria, P. Gambetti and G. Perry, Evidence for oxidative stress in Pick disease and corticobasal degeneration, Brain Res 696 (1995), 268-271.
10. R.J. Castellani, P.L.R. Harris, A. Lecroisey, N. Izadi-Pruneyre, C. Wandersman, G. Perry and M.A. Smith, Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease, Antiox Redox Signal 2 (2000), 137-142.
11. D.R. Crapper McLachlan, A.J. Dalton, T.P. Kruck, M.Y. Bell, W.L. Smith, W. Kalow and D.F. Andrews, Intramuscular desferrioxamine in patients with Alzheimer's disease, Lancet 337 (1991), 1304-1308.
12. M.P. Cuajungco, L.E. Goldstein, A. Nunomura, M.A. Smith, J.T. Lim, C.S. Atwood, X. Huang, Y.W. Farraq, G. Perry and A.I. Bush, Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc, J Biol Chem 275 (2000), 19439-19442.
13. M.E. De Leo, S. Borrello, M. Passantino, B. Palazzotti, A. Mordente, A. Daniele, V. Filippini, T. Galeotti and C. Masullo, Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease, Neurosci Lett 250 (1998), 173-176.
14. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry and P.R. Carey, Metal binding and oxidation of amyloid-β within isolated senile plaques cores: Raman microscopic evidence, Biochemistry 42 (2003), 2768-2773.
15. A. Furuta, D.L. Price, C.A. Pardo, J.C. Troncoso, Z.S. Xu, N. Taniguchi and L.J. Martin, Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus, Am J Pathol 146 (1995), 357-367.
16. D. Ham and H.M. Schipper, Heme oxygenase-I induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides, Cell Mol Biol 46 (2000), 587-596.
17. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L.R. Harris, P.K. Jones, R.B. Petersen, G. Perry and M.A. Smith, Mitochondrial abnormalities in Alzheimer's disease, J Neurosci 21 (2001), 3017-3023.
18. X. Huang, C.S. Atwood, M.A. Hartshorn, G. Multhaup, L.E. Goldstein, R.C. Scarpa, M.P. Cuajungco, D.N. Gray, J. Lim, R.D. Moir, R.E. Tanzi and A.I. Bush, The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38 (1999), 7609-7616.
19. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi and A.I. Bush, Cu(II) potentiation of Alzheimer Aβ neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem 274 (1999), 37111-37116.
20. O.J. Kwon, S.M. Lee, R.A. Floyd and J.W. Park, Thiol-dependent metal-catalyzed oxidation of copper, zinc superoxide dismutase, Biochim Biophys Acta 1387 (1998), 249-256.
21. M.A. Lovell, R.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
22. P.W. Mantyh, J.R. Ghilardi, S. Rogers, E. DeMaster, C.J. Allen, E.R. Stimson and J.E. Maggio, Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide, J Neurochem 61 (1993), 1171-1174.
23. S. Melov, J.A. Schneider, B.J. Day, D. Hinerfeld, P. Coskun, S.S. Mirra, J.D. Crapo and D.C. Wallace, A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase, Nat Genet 18 (1998), 159-163.
24. M. Miyata and J.D. Smith, Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides, Nat Genet 14 (1996), 55-61.
25. A. Nunomura, G. Perry, M.A. Pappolla, R. Wade, K. Hirai, S. Chiba and M.A. Smith, RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease, J Neurosci 19 (1999), 1959-1964.
26. M.A. Pappolla, R.A. Omar, K.S. Kim and N.K. Robakis, Immunohistochemical evidence of oxidative stress in Alzheimer's disease, Am J Pathol 140 (1992), 621-628.
27. M. Perez, J.M. Valpuesta, E.M. de Garcini, C. Quintana, M. Arrasate, J.L. Lopez Carrascosa, A. Rabano, J. Garcia de Yebenes and J. Avila, Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy, Am J Pathol 152 (1998), 1531-1539.
28. G. Perry, L.M. Sayre, C.S. Atwood, R.J. Castellani, A.D. Cash, C.A. Rottkamp and M.A. Smith, The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications, CNS Drugs 16 (2002), 339-352.
29. G. Perry, M.A. Taddeo, R.B. Petersen., R.J. Castellani, P.L.R. Harris, S.L. Siedlak, A.D. Cash, Q. Liu, A. Nunomura, C.S. Atwood and M.A. Smith, Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease, Biometals 16 (2003), 77-81.
30. D.R.D. Premkumar, M.A. Smith, P.L. Richey, R.B. Petersen, R. Castellani, R.K. Kutty, B. Wiggert, G. Perry and R.N. Kalaria, Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease, J Neurochem 65 (1995), 1399-1402.
31. C.A. Rottkamp, A. Nunomura, K. Hirai, L.M. Sayre, G. Perry, M.A. Smith, Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? Mech Ageing Dev 116 (2000), 169-179.
32. L.M. Sayre, G. Perry and M.A. Smith, Redox metals and neurodegenerative disease, Curr Opin Chem Biol 3 (1999), 220-225.
33. L.M. Sayre, G. Perry, C.S. Atwood and M.A. Smith, The role of metals in neurodegenerative diseases, Cell Mol Biol 46 (2000), 731-741.
34. L.M. Sayre, G. Perry, P.L.R. Harris, Y. Liu, K.A. Schubert and M.A. Smith, In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals, JNeurochem 74 (2000), 270-279.
35. L.M. Sayre, M.A. Smith and G. Perry, Chemistry and biochemistry of oxidative stress in neurodegenerative disease, Curr Med Chem 8 (2001), 721-738.
36. H.M. Schipper, S. Cisse and E.G. Stopa, Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain, Ann Neurol 37 (1995), 758-768.
37. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.-D. Yan, D. Stern, L.M. Sayre, V.M. Monnier and G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc Natl Acad Sci USA 91 (1994), 5710-5714.
38. M.A. Smith, R.K. Kutty, P.L. Richey, S.-D. Yan, D. Stern, GJ. Chader, B. Wiggert, R.B. Petersen and G. Perry, Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease, Am J Pathol 145 (1994), 42-47.
39. M.A. Smith, P.L.R. Harris, L.M. Sayre and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci USA 94 (1997), 9866-9868.
40. M.A. Smith, K. Wehr, P.L.R. Harris, S.L. Siedlak, J.R. Connor and G. Perry, Abnormal localization of iron regulatory protein in Alzheimer's disease, Brain Res 788 (1998), 232-236.
41. M.A. Smith, A. Nunomura, X. Zhu, A. Takeda and G. Perry, Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease, Antiox Redox Signal 2 (2000), 413-420.
42. K. Suzuki and R.D. Terry, Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia, Acta Neuropathol 8 (1967), 276-284.
43. R.D. Terry and R. Katzman, Life span and synapses: will there be a primary senile dementia? Neurobiol Aging 22 (2001), 347-348.
44. R.D. Terry, The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis, J Neuropathol Exp Neurol 55 (1996), 1023-1025.
45. R.D. Terry, Cell death or synaptic loss in Alzheimer disease, J Neuropathol Exp Neurol 59 (2000), 1118-1119.
46. M.D. Williams, H. Van Remmen, C.C. Conrad, T.T. Huang, C.J. Epstein and A. Richardson, Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice, J Biol Chem 273 (1998), 28510-28515.
47. M. Wong-Riley, P. Antuono, K.C. Ho, R. Egan, R. Hevner, W. Liebl, Z. Huang, R. Rachel and J. Jones, Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems, Vision Res 37 (1997), 3593-3608.